BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golan T, Atias D, Stossel C, Raitses-Gurevich M. Patient-derived xenograft models of BRCA-associated pancreatic cancers. Adv Drug Deliv Rev 2021;171:257-65. [PMID: 33617901 DOI: 10.1016/j.addr.2021.02.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Satchi-Fainaro R, Florindo HF, Vicent MJ. Clinically-relevant and predictive cancer models for nanomedicine evaluation. Adv Drug Deliv Rev 2022;183:114140. [PMID: 35134434 DOI: 10.1016/j.addr.2022.114140] [Reference Citation Analysis]
2 Zhang H, Wu P, Guo C, Zhang C, Zhao Y, Tan D, An J, Shi C. Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine. Biochem Biophys Rep 2022;31:101291. [PMID: 35669987 DOI: 10.1016/j.bbrep.2022.101291] [Reference Citation Analysis]